[Genetic testing in cardiologic diagnostics]

Area of Science:

• Cardiovascular Genetics
• Molecular Diagnostics
• Genetic Epidemiology

Context:

• Hereditary heart diseases, such as hypertrophic cardiomyopathy and long QT syndrome, and familial hypercholesterolemia, have a significant genetic basis.
• Genetic defects are prevalent in specific populations, with nearly 20% of Finnish hypertrophic cardiomyopathy cases and almost three-fourths of Finnish long QT syndrome cases linked to known mutations.
• Familial hypercholesterolemia exhibits a high prevalence of identifiable gene defects, found in approximately 90% of cases.

Purpose:

• To evaluate the utility of gene testing in identifying hereditary cardiovascular diseases and hyperlipidemia.
• To determine the prevalence of specific genetic mutations in Finnish populations affected by hypertrophic cardiomyopathy and long QT syndrome.
• To assess the application of DNA testing for identifying asymptomatic carriers of familial hypercholesterolemia mutations.

Summary:

• Gene tests are valuable for suspected hereditary heart disease and hyperlipidemia.
• Specific mutations are common in Finnish populations with hypertrophic cardiomyopathy and long QT syndrome.
• DNA testing effectively identifies carriers of familial hypercholesterolemia, enabling targeted medical follow-up and exclusion of unaffected individuals.

Impact:

• Genetic testing facilitates early detection and management of hereditary cardiovascular conditions.
• Identifying mutation carriers allows for personalized risk assessment and preventative strategies.
• DNA testing can optimize healthcare resource allocation by focusing follow-up on individuals with a confirmed genetic predisposition.